WHat do you think about MRNA? It looks cheap at 7.8 P/E with 5.3 debt: capital and the technicals look upward drifty.
Okay, my thoughts on MRNA:
I like Moderna a lot, but as with all biotechs (even a mature rev producing one), they are riskier than traditional pharma. Moderna's vaccine business is rock solid. Sure, 2021 and 2022 rev was likely inflated due to the COVID vaccine, but they have already announced $5B in COVID vaccine sales for 2023. Any downside or regression to the mean is likely public and baked into analyst targets.
Their mRNA tech is outstanding. Huge advancement vs traditional vaccines in terms of development timelines, safety, and adaptability (i.e., dealing with new strains, if relevant). Their vaccine business should grow briskly since their vaccine pipeline is stacked.
The big risk/reward for Moderna is can they apply mRNA to other areas like ONC, CARDIO, and rare diseases? This is the ball game. If yes, Moderna may become a legit pharma/HC big boy in terms of rev and earnings. If no, they will still have a strong vaccine business that will increase share, but this business has some limitations (like population growth and natural herd immunity).
I own a good amount of MRNA via a few HC funds and ETFs. The irrational price spike in 2020/2021 is long over, so now may be a good time to buy (for a trade or hold).
I can post Morningstar's analysis later.